VIRPAX PHARMACEUTICALS INC (VRPX)
US9282512063 - Common Stock
On Monday, there are stocks with unusual volume. Let's take a look.
In today's session, these stocks are experiencing unusual volume.
Let's take a look at the stocks that are in motion in today's session.
Top movers analysis in the middle of the day on 2024-11-25: top gainers and losers in today's session.
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Which stocks are gapping on Monday?
Top movers in Friday's after hours session
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Which stocks are most active on Friday?
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume!
Unusual volume stocks are being observed in Friday's session.
Volume analysis on 2024-11-22: stocks with an unusual volume in today's session.
Which stocks are gapping on Friday?
Gap analysis on 2024-11-22: gap up and gap down stocks in today's session.
Which stocks are moving before the opening bell on Friday?
Curious about the stocks that are showing activity before the opening bell on Friday?
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
Virpax Pharmaceuticals just reported results for the second quarter of 2024.
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virpax Pharmaceuticals (NASDAQ:VRPX) just reported results for the second quart...
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Virpax Regains Compliance with Nasdaq Minimum Bid Price
Why Is Hawaiian Electric (HE) Stock Up 15% Today?
Hawaiian Electric stock is up on Wednesday after HE investors learned of a reported settlement tied to the 2023 Maui fires.
PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update
Plug Power stock is up on Wednesday after the company provided investors with an update on its hydrogen refueling stations in Europe.
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?
Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company.